Biogen Inc. CEDEAR (BIIB)
BCBA
Closed
Aug 21, 2026
Day's Range
26,240.0052 wk Range
13,075.00Overview - BIIB - Biogen Inc. CEDEAR
Key Statistics
Valuation
Enterprise Value
35,214.71T
P/E (Trailing)
‪3.14‬
PEG Ratio
‪-0.03‬
Price / Sales (TTM)
‪390.75‬
Price / Book
‪0.83‬
EV / EBITDA
‪6,992.27‬
Profitability
Gross Margin
‪71.60%‬
Profit Margin
‪8.32%‬
Operating Margin
‪25.05%‬
Return on Assets
‪5.20%‬
Return on Equity
‪4.57%‬
Ownership
Shares Outstanding
147.70M
Float
881.55M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.16‬
50-Day Avg
‪24,794.00‬
200-Day Avg
‪22,025.70‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BIIB - Biogen Inc. CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- BIIBBCBABiogen Inc. CEDEAR3.97TMarket Cap+47.55%52-week change3.02P/E (Trailing)‪8.32%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR345.82TMarket Cap+43.38%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.31P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR101.00TMarket Cap+18.54%52-week change6.36P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.64TMarket Cap+33.95%52-week change7.75P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.72.76TMarket Cap+40.06%52-week change5.24P/E (Trailing)‪18.87%‬Profit Margin
Profile Summary - BIIB - Biogen Inc. CEDEAR
About
Biogen Inc. is an American multinational biotechnology company specializing in treatments for neurological diseases and rare conditions. Based in Cambridge, Massachusetts, the company develops and commercializes a diverse portfolio of therapies including LEQEMBI and ADUHELM for Alzheimer's disease, TECFIDERA and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
